Cupid spurts on receiving USFDA’s nod for new variants of condoms

11 Aug 2020 Evaluate

Cupid scrip is currently trading at Rs. 262.00, up by 12.80 points or 5.14% from its previous closing of Rs. 249.20 on the BSE.

The scrip opened at Rs. 256.00 and has touched a high and low of Rs. 266.00 and Rs. 256.00 respectively. So far 21572 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 266.00 on 11-Aug-2020 and a 52 week low of Rs. 115.00 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 266.00 and Rs. 224.90 respectively. The current market cap of the company is Rs. 332.38 crore.

The promoters holding in the company stood at 45.06%, while Institutions and Non-Institutions held 0.66% and 54.27% respectively.

Cupid has received US Food and Drug Administration (USFDA) 510(k) approval for additional four variants of CUPID Brand Male Natural Rubber Latex Condoms in addition of approval for one variant already obtained by the company, to market these products in US market.

Cupid manufactures and markets varieties of male and female condoms, water based lubricant, latex dental dams and probe covers. Cupid has a diverse product basket available in over 25 countries worldwide.

Cupid Share Price

2430.45 76.30 (3.24%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2268.25
Godrej Consumer Prod 1255.00
Dabur India 525.00
Colgate Palmol. (I) 2741.95
Galaxy Surfactants 2270.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.